IMPACT OF PRIOR BIOLOGIC EXPOSURE ON THE DURABILITY OF 3-YEAR CONTINUOUS OZANIMOD TREATMENT

Severine Vermeire  ¹     Anita Afzali  ²     Douglas C. Wolf  ³     Miguel Regueiro  ⁴     Dimpy Mehra  ⁵     Hsiuanlin Wu  ⁵     Anjali Jain  ⁵     Jean-Frédéric Colombel  ^6    
1 University of Leuven, Leuven, Belgium
² Division of Digestive Diseases, University of Cincinnati, Cincinnati, United States
³ Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, United States
⁴ Cleveland Clinic, Cleveland, United States
⁵ Bristol Myers Squibb, Princeton, United States
⁶ Icahn School of Medicine of Mount Sinai, New York, United States

Topic
IBD

Session
Medical therapy in IBD: A potpourri of options (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)